Invention Grant
- Patent Title: Peptide-peptidase inhibitor conjugates and methods of using same
- Patent Title (中): 肽肽酶抑制剂缀合物及其使用方法
-
Application No.: US12785396Application Date: 2010-05-21
-
Publication No.: US08759295B2Publication Date: 2014-06-24
- Inventor: Soumitra S. Ghosh , Josue Alfaro-Lopez , Lawrence J. D'Souza , Odile Esther Levy , Qing Lin , Christopher J. Soares
- Applicant: Soumitra S. Ghosh , Josue Alfaro-Lopez , Lawrence J. D'Souza , Odile Esther Levy , Qing Lin , Christopher J. Soares
- Applicant Address: US CA San Diego US DE Wilmington
- Assignee: Amylin Pharmaceuticals, LLC,Astrazeneca Pharmaceuticals LP
- Current Assignee: Amylin Pharmaceuticals, LLC,Astrazeneca Pharmaceuticals LP
- Current Assignee Address: US CA San Diego US DE Wilmington
- Agency: Womble Carlyle Sandridge & Rice LLP
- Agent Mark J. Pino; Alireza Behrooz
- Main IPC: A61K38/26
- IPC: A61K38/26 ; C07K14/605 ; C07K19/00 ; A61P3/10 ; A61P9/00 ; A61P9/04 ; A61P9/08 ; A61P9/10 ; A61P9/12
Abstract:
Peptide-peptidase inhibitor conjugate molecules are disclosed. These conjugate molecules are useful as agents for the treatment and prevention of metabolic and cardiovascular diseases, disorders, and conditions. Such diseases, conditions and disorders include, but are not limited to, hypertension, dyslipidemia, cardiovascular disease, eating disorders, insulin-resistance, obesity, and diabetes mellitus of any kind, and other diabetes-related disorders.
Public/Granted literature
- US20100292172A1 Peptide-Peptidase Inhibitor Conjugates and Methods of Using Same Public/Granted day:2010-11-18
Information query
IPC分类:
